Ann: UTS Strategic Partnership, page-3

That might be waffle to you, but I suspect that you hold this view is just one reason why you were ill equipped for investing in this technology.

Models of care do need to change to enable broader use of Heracare. This is essential. Clinicians will listen to the scientific evidence of independent research bodies over the voices of self-motivated companies.

HMD will need assistance with harnessing the data collected if it is to provide useful insights to clinicians that is the very basis of HMD's new business model. Again, I get this from the announcement.

We also would like some non-dilutive funding.

Not every announcement can be a commercial sale. It's just the reality. We all acknowledge HMD should be further ahead than it is now.

But does this announcement broaden and deepen HMD's prospect of success? Yes, of course it does.

Always first to comment in your overly pessimistic way. If you've given up, take a hike. Sell or accept your loss and move on.

It seems to me that you are intent on making sure that HMD is a failure, which is frankly just turd behaviour.